Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

Deerfield, Illinois, Feb. 27, 2025 (GLOBE NEWSWIRE) -- DEERFIELD, IL. February 27, 2025 – Vantage Specialty Chemicals, Inc., (Vantage) today announced that its VYCERIN™ API Glycerin, USP is listed on ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

Artificial intelligence and machine learning can help overcome poor solubility and bioavailability. Artificial intelligence (AI) and machine learning (ML) in the biopharmaceutical industry have been ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

Pharmaceutical companies are increasingly focusing on acquisitions in the Active Pharmaceutical Ingredients (API) and formulation space to consolidate market share and diversify portfolios, global ...

Matching excipients to API properties is essential. Hot-melt extrusion (HME) enables formation of amorphous solid dispersions (ASDs) of crystalline compounds, trapping the molecules in less-stable ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...